Assenagon Asset Management
ABMD

Assenagon Asset Management’s Abiomed Inc ABMD Stock Holding History

Assenagon Asset Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-3,647
Closed -$896K – 1501
2022
Q3 		$896K Buy
3,647
+1,758
+93% +$475K ﹤0.01% 953
2022
Q2 		$468K Sell
1,889
-254
-12% -$68.5K ﹤0.01% 1238
2022
Q1 		$710K Sell
2,143
-565
-21% -$174K ﹤0.01% 1141
2021
Q4 		$973K Buy
2,708
+513
+23% +$173K ﹤0.01% 1043
2021
Q3 		$715K Buy
2,195
+957
+77% +$324K ﹤0.01% 990
2021
Q2 		$386K Sell
1,238
-11,537
-90% -$3.54M ﹤0.01% 1074
2021
Q1 		$4.07M Buy
+12,775
New +$4.09M 0.02% 556
2020
Q4 		– Sell
-13,129
Closed -$3.64M – 1313
2020
Q3 		$3.64M Buy
13,129
+6,055
+86% +$1.74M 0.02% 418
2020
Q2 		$1.71M Sell
7,074
-16,526
-70% -$3.32M 0.01% 648
2020
Q1 		$3.43M Buy
+23,600
New +$3.92M 0.03% 264
2019
Q2 		– Sell
-7,301
Closed -$2.08M – 1213
2019
Q1 		$2.08M Buy
7,301
+2,875
+65% +$956K 0.02% 506
2018
Q4 		$1.44M Buy
+4,426
New +$1.54M 0.02% 554

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Assenagon Asset Management's ABMD Position: Q4 2022 in Review

Assenagon Asset Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 3,647 shares — an estimated $896K sold.

Assenagon Asset Management first reported a position in ABMD in Q4 2018 and held it in 12 quarters. The position peaked at $4.07M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Assenagon Asset Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Assenagon Asset Management sold 3,647 Abiomed Inc shares in Q4 2022, an estimated $896K.
  • Assenagon Asset Management first reported a position in Abiomed Inc in Q4 2018 and held it in 12 quarters.
  • Assenagon Asset Management's Abiomed Inc position peaked at $4.07M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Assenagon Asset Management's 13F filing for Q4 2022, filed 12 Jan 2023.